These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6278020)

  • 1. Chemotactic factor inactivation by stimulated human neutrophils mediated by myeloperoxidase-catalyzed methionine oxidation.
    Clark RA; Szot S
    J Immunol; 1982 Apr; 128(4):1507-13. PubMed ID: 6278020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotactic factors trigger their own oxidative inactivation by human neutrophils.
    Clark RA
    J Immunol; 1982 Dec; 129(6):2725-8. PubMed ID: 7142703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system.
    Clark RA; Klebanoff SJ
    J Clin Invest; 1979 Oct; 64(4):913-20. PubMed ID: 225353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of n-formyl methionyl chemotactic peptide by human neutrophils.
    Tsan MF; Denison RC
    J Immunol; 1981 Apr; 126(4):1387-9. PubMed ID: 6259258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative inactivation of pneumolysin by the myeloperoxidase system and stimulated human neutrophils.
    Clark RA
    J Immunol; 1986 Jun; 136(12):4617-22. PubMed ID: 3011897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of neutrophil inflammatory mediator release: chemotactic peptide activation of stimulus-dependent cytotoxicity.
    English D; Lukens JN
    J Immunol; 1983 Feb; 130(2):850-6. PubMed ID: 6294178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme.
    Bender JG; McPhail LC; Van Epps DE
    J Immunol; 1983 May; 130(5):2316-23. PubMed ID: 6300243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic factor inactivation by myeloperoxidase-mediated oxidation of methionine.
    Clark RA; Szot S; Venkatasubramanian K; Schiffmann E
    J Immunol; 1980 Apr; 124(4):2020-6. PubMed ID: 6245132
    [No Abstract]   [Full Text] [Related]  

  • 9. Myeloperoxidase-mediated modulation of chemotactic peptide binding to human neutrophils.
    Lane TA; Lamkin GE
    Blood; 1983 Jun; 61(6):1203-7. PubMed ID: 6301583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonists of the formylated peptide chemoattractants: structure-activity comparisons with formyl-methionyl-leucyl-phenylalanine-OH.
    Freer RJ; Day AR; Muthukumaraswamy N; Showell HJ; Becker EL
    Kroc Found Ser; 1981; 14():161-8. PubMed ID: 6947071
    [No Abstract]   [Full Text] [Related]  

  • 11. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient.
    Stendahl O; Coble BI; Dahlgren C; Hed J; Molin L
    J Clin Invest; 1984 Feb; 73(2):366-73. PubMed ID: 6321554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system.
    el-Hag A; Clark RA
    J Immunol; 1987 Oct; 139(7):2406-13. PubMed ID: 2821114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD; Fiegel VD; Herron MJ; Simmons RL
    J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
    Shingu M; Nobunaga M
    Am J Pathol; 1984 Nov; 117(2):201-6. PubMed ID: 6388344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
    J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of glucosamine by activated human neutrophils. A myeloperoxidase-mediated process.
    Bearman SI; Schwarting GA; Kolodny EH; Babior BM
    J Lab Clin Med; 1980 Nov; 96(5):893-902. PubMed ID: 6252269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms.
    McPhail LC; Snyderman R
    J Clin Invest; 1983 Jul; 72(1):192-200. PubMed ID: 6409928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase-dependent loss of malondialdehyde: a limitation for detecting neutrophil-mediated lipid peroxidation.
    Winterbourn CC; Carr AC
    Arch Biochem Biophys; 1993 May; 302(2):461-7. PubMed ID: 8387748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.